EMA Risk Management Virtual Information Day

Registered participants find access to the virtual conference in their DIA account. This virtual information day provides an update of ongoing Agency’s activities on medicines’ risk management.

Back to Agenda

Session 2

Speaker(s)

GVP Module XVI – Addendum III: Pregnancy Prevention Programme – Where We Are

Priya Bahri, PhD, RPh

European Medicines Agency, Netherlands

Senior Lead (Pharmacovigilance and Risk Management Guidance and Policy)

Treating Pregnant and Breastfeeding Women: The Reality of Clinical Practice as a GP and Pharmacist

Paul Ryan

PharmaBuddy.ie, GPConsult.ie, Dermabuddy.ie and GPConsult.co.uk, Ireland

GP and Pharmacist, Founder of PrescriptionRevision.com

Measuring the effectiveness of pregnancy prevention programme for valproate-challenges and lessons learned.

Liana Gross-Martirosyan

Medicines Evaluation Board (MEB), Netherlands

PRAC Member

Have an account?